Prof Stefan Verheye (ZNA Middelheim Antwerp, Antwerp, BE) discusses recent trial results investigating the DynamX Bioadaptor, a novel uncaging platform, for coronary artery revascularization.
Questions
1. What was the rationale for the study?
2. Can you tell us about the technology studied? What was the study?
3. What were your findings?
4. What conclusions can be made and what further research is needed?
5. What is the study's take-home message?
Recorded remotely from Antwerp, 2020.
Interviewer: Mirjam Boros
Recording Editor: Natascha Wienand